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Synapsins are a family of synaptic vesicle proteins that are important for neurotransmitter release. Here we have used triple knock-out
(TKO) mice lacking all three synapsin genes to determine the roles of synapsins in the release of two monoamine neurotransmitters,
dopamine and serotonin. Serotonin release evoked by electrical stimulation was identical in substantia nigra pars reticulata slices
prepared from TKO and wild-type mice. In contrast, release of dopamine in response to electrical stimulation was approximately doubled
in striatum of TKO mice, both in vivo and in striatal slices, in comparison to wild-type controls. This was due to loss of synapsin III,
because deletion of synapsin III alone was sufficient to increase dopamine release. Deletion of synapsins also increased the sensitivity of
dopamine release to extracellular calcium ions. Although cocaine did not affect the release of serotonin from nigral tissue, this drug did
enhance dopamine release. Cocaine-induced facilitation of dopamine release was a function of external calcium, an effect that was
reduced in TKO mice. We conclude that synapsins play different roles in the control of release of dopamine and serotonin, with release of
dopamine being negatively regulated by synapsins, specifically synapsin III, while serotonin release appears to be relatively independent
of synapsins. These results provide further support for the concept that synapsin function in presynaptic terminals varies according to the
neurotransmitter being released.
Introduction
Synapsins are phosphoproteins that bind to the cytosolic surface
of synaptic vesicles and represent almost 10% of the total protein
content of synaptic vesicles. There are three mammalian synapsin
genes (synapsin I, II, and III), with alternative splicing creating 10
known synapsin isoforms. Synapsins are differentially expressed
in nerve terminals, with synapsins I and II present in most areas of
the adult brain while synapsin III expression is more restricted
(Pieribone et al., 2002). Synapsins are thought to play a role in
segregating vesicles into a reserve pool that is located away from
the active zone, where exocytosis occurs (Greengard et al., 1993).
This hypothesis is supported by observations showing that per-
turbing synapsins by microinjection of anti-synapsin antibodies
(Pieribone et al., 1995) or synapsin peptides (Hilfiker et al., 2005)
disrupts a distal, reserve pool of vesicles, sparing vesicles in the
active zone. It is thought that mobilization of vesicles from the
reserve pool is triggered by calcium-dependent phosphorylation
of synapsins (Llinás et al., 1991; Greengard et al., 1993; Chi et al.,
2003). More recent evidence suggests that synapsins are also im-
portant regulators of exocytosis, vesicle recycling, and vesicle in-
tegrity at the active zone (Fdez and Hilfiker, 2006; Evergren et al.,
2007).
Synapsin knock-out (KO) mice have provided further insights
into the role of synapsins in the regulation of neurotransmitter
release. While deletion of individual synapsin genes (Ferreira et
al., 2000; Feng et al., 2002) or genes for both synapsins I and II
(Rosahl et al., 1995; Lonart and Simsek-Duran, 2006) affects syn-
aptic vesicle pool dynamics, interpretation of results from such
genotypes are hindered by possible compensation caused by re-
maining synapsin isoforms and differential expression of syn-
apsins across brain regions. These problems have been solved by
generating triple knock-out (TKO) mice that lack all three known
synapsin genes. TKO mice exhibit reduced reserve pools in both
glutamatergic and GABAergic nerve terminals, evident as
changes in vesicle distribution and in neurotransmitter release
during trains of action potentials (Gitler et al., 2004). However,
when using single action potentials as stimuli to monitor release
from the readily releasable pool of synaptic vesicles, release of
GABA from this pool is reduced, while release of glutamate is not.
This suggests that the function of synapsins at presynaptic termi-
nals varies according to the type of neurotransmitter used.
Here we have extended the analysis to the release of dopamine
(DA) and serotonin (5-HT), comparing release of these two
monoamine neurotransmitters in synapsin TKO mice both in
brain slices and in vivo. DA release was enhanced in the absence of
synapsins, while 5-HT release from brain slices was identical in
the two genotypes. The altered DA release in TKO mice appeared
to be due to deletion of synapsin III since release was similarly
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altered in mice with a synapsin III deletion. The dependence of
DA release on extracellular calcium was found to differ between
TKO and wild-type (WT) mice, with TKO mice being more sen-
sitive to calcium. The ability of cocaine to increase release of DA
was reduced in synapsin TKO mice, supporting the assertion that
synapsins contribute to the presynaptic actions of cocaine (Ven-
ton et al., 2006). In contrast, cocaine did not affect release of 5-HT
in either genotype. These findings demonstrate that synapsins
play different regulatory roles in nerve terminals releasing DA
and 5-HT.
Materials and Methods
Animals. Homozygous mutant synapsin TKO, synapsin III knock-out
(S3KO), and WT male and female mice were bred at Duke University as
previously described (Gitler et al., 2004). Mice were age and sex matched
and experiments were conducted with protocols approved by the Insti-
tutional Animal Care and Use Committees of both Duke University and
the University of North Carolina at Chapel Hill.
Electrochemistry. Cylindrical carbon-fiber microelectrodes (6 m di-
ameter, Thornel T-650; Amoco) were fabricated as previously described
(Bath et al., 2000). A carbon fiber was aspirated into glass capillary (1.2
mm  0.68 mm, 4 inches; AM Systems). The electrodes were pulled on a
vertical capillary puller (Narishige) and the excess carbon fiber was
trimmed to 50 m. Waveform application, current monitoring, and
stimulus application were all controlled by locally written software (Tar-
heel CV, Labview) through a home-built potentiostat (UEI, UNC elec-
tronics shop).
For DA detection, the carbon-fiber electrode was held at 0.40 V
versus an Ag/AgCl reference electrode between voltage scans. Detection
in brain slices was achieved by application of a triangular waveform:
0.40 V to 1.00 V to 0.40 V with a scan rate of 600 V/s and repeated at
60 Hz. This waveform provided high temporal resolution (Bath et al.,
2000). The waveform for in vivo use employed the same voltages, but was
at 300 V/s and was repeated at 10 Hz; this method provided improved
sensitivity (Baur et al., 1988). The current at the peak oxidation potential
for DA (0.50 – 0.70 V vs Ag/AgCl) was used to evaluate DA concentration
changes.
For 5-HT detection the electrode potential between scans was 0.20 V vs
Ag/AgCl. The cyclic voltammogram was obtained with an initial scan to
1.00 V, back to 0.10 V, and then scanned to 0.20 V at 1000 V/s applied
at 10 Hz. The positive rest potential minimizes electrode fouling from
5-HT reduction products (Jackson et al., 1995). In addition, the rapid
scan rate enables side-reactions characteristic of electrochemical detec-
tion of 5-HT to be outrun. For both DA and 5-HT, the electrodes were
calibrated in a flow injection system with a 1 M bolus of the analyte of
interest. Calcium ions inversely reduce the sensitivity of electrodes in a
linear manner. These changes in electrode sensitivity were accounted for
in calibration (Kume-Kick and Rice, 1998).
Slice experiments. Mice were anesthetized with ether and decapitated.
The brain was rapidly removed and placed on ice. Coronal brain slices
(300 m) containing the caudate–putamen or substantia nigra, pars re-
ticulata (SNr), were prepared in ice-cold artificial CSF (aCSF) using a
Lancer Vibratome (World Precision Instruments). The aCSF contained
the following (in mM): 20 HEPES, 2.4 CaCl2, 1.2 MgCl2, 1.2 NaH2PO4,
2.45 KCl, 126 NaCl, 11 glucose, and 25 NaHCO3. All reagents were
obtained from Sigma-Aldrich. Cocaine, picrotoxin, CNQX, and
mecamylamine were dissolved in doubly deionized water at a concentra-
tion of 2 mM. Final dilutions were made in aCSF and applied to the slice
for 35 min. before measurements. The pH was adjusted to 7.4 and the
aCSF was saturated with 95% O2/5% CO2. Slices were superfused in
aCSF at 37°C for 35– 40 min. before recording. Recordings were per-
formed on a microscope (Nikon Fn-1, Gibraltar Stage) fitted with a slice
perfusion chamber (Warner Instruments).
Neurotransmitter release was evoked by local electrical stimulation
delivered with a tungsten bipolar stimulating electrode placed on the
surface of the slice (FHC). The stimulus consisted of a computer gener-
ated, biphasic (2 ms per phase), constant current (350 A) pulse. A single
stimulation pulse was used to evoke striatal DA release in the caudate–
putamen while a 20 pulse, 100 Hz stimulation train was used to evoke
5-HT release in the SNr. The current pulse was optically isolated from the
preparation (NL 800; Neurolog, Medical Systems). Stimuli were given at
regular intervals. Neurotransmitter release was detected with a carbon-
fiber microelectrode placed 75–100 m into the slice at a distance of
100 –200 m from the stimulating electrode. Electrode placements were
made with micromanipulators and the aid of the microscope.
To determine the amount of DA release from each genotype, the max-
imal release at four locations in a single slice was recorded over a 20 min
period, and the values were averaged together. The responses from each
genotype were pooled. To examine the effects of cocaine and Ca 2,
measurements were made at a single site that exhibited maximal DA
release. The amount of 5-HT released was determined in a similar fash-
ion to DA with the exception that three locations were used and data were
pooled.
In vivo experiments. Mice were anesthetized with urethane (1.5 g/kg,
i.p.) and placed in a stereotaxic frame. The coordinates relative to bregma
for placement of the working electrode in the caudate–putamen were as
follows (in mm): AP 1.1, ML 1.2, and DV 2.2 (Paxinos et al., 1985).
The stimulating electrode was placed in the medial forebrain bundle at
AP 2.4, ML 1.1, and DV 4.5. The dorsal–ventral placement of both
the working and stimulating electrodes was adjusted in small increments
to find maximal DA release. An Ag/AgCl reference electrode was inserted
into the contralateral side of the brain.
HPLC. Tissue samples were punched from slices (500 m thickness)
with a 2.5 mm diameter cork borer. The tissue was blotted dry, weighed,
and homogenized with a wand sonicator (Fisher Scientific) in 200 l of
0.1N perchloric acid spiked with 1 M hydroquinone. Following centrif-
ugation at 6000 rpm for 10 min, the supernatant was removed and fil-
tered with a 0.2 m syringe filter unit (Millex-LG). Injections (10 l)
were made onto a reverse-phase column (C-18, 5 m, 4.6  250 mm,
Waters symmetry 300). The mobile phase (prepared in HPLC grade
water) contained 0.1 M citric acid, 0.1 mM EDTA, and 1 mM hexyl sodium
sulfate, pH 3.5. Catecholamines were detected with a thin-layer radial
electrochemical flow cell (BASi), with the working electrode at 700 mV
versus the Ag/AgCl reference electrode. Catecholamine standards were
prepared from 10 mM stock solutions in 0.1N perchloric acid.
Kinetic modeling. Nonlinear regression was used to extract kinetic con-
stants associated with release and uptake of DA from the extracellular
space (Wu et al., 2001). Concentration traces were fit using a Michaelis-
Menten-based model (Wightman et al., 1988). The nonlinear regression
procedure used in conjunction with deconvolution of the measured re-
sponses from the electrode time constant (15–50 ms for a 60 Hz sampling
rate) improves accuracy for release and uptake measurements (Garris
and Wightman, 1995; Venton et al., 2002). The output of the regression
is the amount of DA released for each stimulus pulse ([DA]p) during a
train of stimuli and the Vmax for uptake. The Km value was fixed at 200 nM
for DA (Near et al., 1988) and 170 nm for 5-HT (John et al., 2006). When
competitive uptake inhibitors such as cocaine were used, Vmax was fixed
at predrug values to determine the apparent Km.
Data analysis. Data are shown as mean  SEM. The n values are the
number of animals used for a specific experiment. In addition to this
replicate number, multiple locations and stimuli were used to reduce
random error in the electrochemical measurements. Tests of significance
included Student’s t test, one-way ANOVA with Student–Newman–
Keuls post hoc, two-way repeated-measures ANOVA with Bonferroni
comparisons post hoc, and three-way repeated measures with Bonferroni
comparisons post hoc where applicable.
Results
Serotonin release in substantia nigra brain slices
The influence of synapsins on electrically evoked release of 5-HT
(Bunin et al., 1998) was evaluated by comparing 5-HT release in
slices prepared from the brains of TKO and WT mice. In these
experiments, we used local electrical stimulation with a stimulus
train consisting of 20 biphasic pulses (2 ms each phase) of 350 A
at 100 Hz. 5-HT release was monitored by cyclic voltammetry
and the voltammogram at the peak (Fig. 1, inset) was used to
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positively identify the released substance. 5-HT release evoked
under such conditions was consistent over several hours if the
stimulus trains were separated by intervals of 5 min or longer
(Bunin et al., 1998). To minimize the contribution of spatial
heterogeneity of 5-HT release sites, measurements were made at
three different positions of the carbon-fiber electrode within each
SNr slice and then averaged together.
In slices from both genotypes, 5-HT release began promptly at
the onset of the stimulus and ended as soon as the stimulus
stopped, with the concentration of 5-HT returning to prestimu-
lus values over the next 1–2 s (Fig. 1). Measurements of the peak
concentration of released 5-HT ([5-HT]max) from 10 animals of
each genotype showed that the mean [5-HT]max was 130  8 nM
in WT mice and 140  7 nM in TKO mice; these values are not
significantly different from each other ( p  0.05). The maximal
rate of 5-HT uptake (Vmax) was evaluated in WT and TKO slices
by using nonlinear regression to model the decay of the traces (see
Materials and Methods). The Vmax of 5-HT uptake for WT and
TKO animals was 450  70 nM/s and 370  80 nM/s, respectively.
These values are not significantly different from each other ( p 
0.05) and are similar to those reported previously for the SNr
(John et al., 2006).
Tissue 5-HT content in the SNr was measured by HPLC. Tis-
sue punches taken from TKO and WT mice (four animals per
genotype) revealed that tissue levels of 5-HT were not different
between genotypes (Table 1).
Synapsins affect dopamine release in striatal brain slices
Local electrical stimulation was used to evoke DA release from
terminals in the caudate–putamen of coronal brain slices from
synapsin TKO and WT animals. In this case, a single biphasic
current pulse (2 ms each phase) of 350 A was used as a stimulus,
with cyclic voltammetry used to positively identify the signal as
DA (Fig. 2A, inset). The peak oxidation potential of DA occurs at
0.6 V versus Ag/AgCl, similar to that shown for the peak oxi-
dation of 5-HT. However, the cyclic voltammograms for the two
substances differ on the reverse scan, with the peak for reduction
of the dopamine-o-quinone occurring at approximately 0.3 V
with the waveform used, whereas the reduction peak following
5-HT oxidation occurs at more positive potentials (Jackson et al.,
1995).
Figure 1. Representative traces of 5-HT release in coronal brain slices containing the SNr
from WT and TKO mice evoked by a 100 Hz stimulation train (20 pulses, black line). Inset, The
cyclic voltammogram is used for identification of 5-HT.
Table 1. Neurotransmitter content from tissue samples containing either the
dorsolateral striatum (DA) or the substantia nigra pars reticulata (5-HT)
Animal Striatal tissue DA content (g/g) SNr tissue 5-HT content (g/g)
WT 4.97  0.96 1.03  0.20
TKO 4.68  0.60 0.74  0.10
Data is from four animals of each genotype and is expressed as mean  SEM. No statistical differences were found
between genotypes for either neurotransmitter ( p  0.05, Student’s t test).
Figure 2. DA release evoked by a single stimulation pulse (vertical black line) in striatal brain
slices from WT or TKO animals. A, Representative responses of stimulated DA release; the time of
stimulation is shown by the vertical bar. Inset, The cyclic voltammogram identifies the released
neurotransmitter as DA. B, Mean [DA]max from multiple locations of each genotype show an
approximate twofold difference in striatal DA release (**p  0.01, n  8 TKO, n  6 WT). C,
Representative traces of DA release evoked by a single stimulus pulse in WT or S3KO animals.
Time of stimulus is shown as a vertical black line. D, Measurements of DA release at multiple
locations of each genotype indicate that S3KO slices have approximately double the amount of
DA release measured in WT slices (*p  0.05, n  5 S3KO, n  5 WT).
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DA release was evoked every 5 min at four different sites per
slice, using the single biphasic pulse described above, and the
values of maximal DA release ([DA]max) determined at each site
were pooled for each genotype. In every experiment, DA release
was observed at the onset of stimulation and then declined back
to prestimulus values within 1 s after cessation of the stimulation
(Fig. 2A). The [DA]max was significantly greater ( p  0.01) in
brain slices from TKO mice than in slices prepared from WT
mice, being 1.31  0.09 M (n  6) for WT and 3.31  0.40 M
(n  8) for TKO slices (Fig. 2B). The Vmax for DA uptake was
evaluated with the same procedure described above for 5-HT
uptake. The analysis revealed that the Vmax values for DA uptake
were not significantly different between genotypes, at 6.00  0.40
M/s for WT and 6.20  0.50 M/s for TKO samples. These
values are slightly higher than those reported previously in WT
mice (Johnson et al., 2006).
Because synapsins I and II are lacking in DA terminals (Bogen
et al., 2006), it is likely that synapsin III is the isoform that con-
trols DA release. To test this prediction, DA release was compared
in caudate–putamen slices of S3KO and WT animals. Release of
DA in S3KO brain slices was significantly higher ( p  0.05) than
in WT slices (Fig. 2C), with [DA]max being 3.06  0.55 M (n 
5) in S3KO and 1.22  0.13 M in WT slices (n  5) (Fig. 2D).
DA uptake values were not different between genotypes, 5.97 
0.58 M/s for S3KO (n  5) and 6.16  0.38 M/s for WT slices
(n  5). A comparison of the mean [DA]max in TKO and S3KO
groups showed that these values are not statistically different. The
similar amounts of DA release in TKO and S3KO slices indicate
that a synapsin III gene product is responsible for regulating DA
release.
To determine whether the previously reported changes in re-
lease of glutamate or GABA (Gitler et al., 2004) underlie the
changes in DA release observed in TKO animals, we repeated our
measurements in the presence of CNQX, to block AMPA recep-
tors, or picrotoxin to block GABAA receptors. CNQX increased
DA release while picrotoxin depressed it; however, the difference
in [DA]max between genotypes remained unchanged (supple-
mental Table S1, available at www.jneurosci.org as supplemental
material). Thus, the difference between TKO and WT mice does
not arise from differential regulation of DA release by glutamate
or GABA. Because spontaneous release of acetylcholine also reg-
ulates DA release (Zhou et al., 2001), we further measured DA
release in the presence of mecamylamine, an antagonist of nico-
tinic acetylcholine receptors. Consistent with previous reports,
we found that mecamylamine reduced DA release. However, the
degree of reduction in DA release was not different between ge-
notypes (supplemental Table S1, available at www.jneurosci.org
as supplemental material). Thus, the increase in DA release in
synapsin TKO and S3KO mice also is not a result of altered cho-
linergic signaling at DA terminals.
Dopaminergic neurons are known to release only a small frac-
tion of their total stores to individual stimulus pulses (Guberna-
tor et al., 2009). To determine whether the increased release of
DA observed in TKO mice was due to the striatum containing
greater amounts of DA, we used HPLC to analyze the DA content
of striatal tissue. No significant differences in the amounts of
tissue DA in the striatum were found between the two genotypes
(Table 1), indicating that the increased amount of DA release
found in TKO mice was not due to larger DA stores, but instead is
due to electrical stimulation releasing a larger fraction of these
stores.
Given that synaptic depression is altered in synapsin TKO
mice (Gitler et al., 2004), we asked whether loss of synapsins
affects DA release during repetitive stimulation. With either 0.3 s
or 3 min intervals between stimuli, the amount of DA released per
stimulus was depressed during repetitive stimulation and no dif-
ferences in this activity-dependent decrement in DA release were
observed between slices from WT and TKO mice (Fig. 3). At
stimulus intervals of 5 min, the amount of DA released per stim-
ulus was constant in WT slices but there was a small reduction in
DA release that was not significant (main effect of genotype, F 
5.12, p  0.054) in TKO slices after six or more stimuli. This
might reflect the smaller size of the reserve pool of DA in TKO
neurons (Venton et al., 2006).
Synapsins also affect striatal dopamine release in vivo
We next assessed whether synapsins influence the amount of DA
released in vivo by measuring DA release in the brains of anesthe-
tized TKO and WT mice. In these experiments, DA release in the
caudate–putamen was evoked by electrical stimulation of the me-
dial forebrain bundle, rather than by the local electrical stimula-
tion that was used in our brain slice experiments. As reported
previously, the smaller amounts of DA released per stimulus in
vivo made it necessary to deliver repeated stimuli to elicit detect-
able amounts of DA release (Venton et al., 2006). Consistent with
the results of our slice experiments, 5 min interstimulus intervals
were required to observe consistent amounts of DA release in
response to each stimulus. Figure 4A shows averaged measure-
ments of DA release measured in TKO and WT mice in response
to a brief train of 20 Hz stimuli (0.5 s duration, 300 A; n  8 for
each genotype). At this frequency, trains of activity in WT ani-
mals led to a concentration change that approached steady state
during the stimulus, a response that has previously been docu-
mented in rats in vivo (Wightman et al., 1988).
The larger amounts of DA released from TKO terminals led
to the different shapes of the DA concentration profiles seen in
Figure 4 A, where the DA concentration measured during
stimulation more closely approached a steady state during the
stimulation in WT than in TKO animals. Transmission at do-
paminergic synapses is a balance between DA release and uptake:
because of this balance, DA concentration in WT animals reaches
a steady plateau during the stimulus train. In contrast, the DA
concentration continually increases when larger amounts of DA
are released, because DA transport becomes saturated and
thereby permits continued accumulation of extracellular DA
(Wightman et al., 1988). Such behavior for DA release in the
TKO mice presumably is due to the larger amounts of DA
release in these mice.
Figure 3. The effects of repetitive stimuli on DA release. Single stimuli were applied at
intervals of 0.3 s, 3 min, and 5 min, and the amount of DA released in response to each stimulus
was normalized to the amount of DA released in response to the first stimulus.
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Given that repetitive stimulation was required to elicit mea-
surable DA release, we next evaluated how loss of synapsins af-
fected the frequency dependence of DA release. At all stimulus
frequencies tested, DA release was greater in TKO animals than in
WT mice (Fig. 4B) (main effect of genotype, F  6.86, p  0.05).
At a stimulus intensity of 350 A, the data could be described by
a model that assumed that the amount of DA released per stim-
ulus pulse ([DA]p) in vivo was constant. [DA]p was found to be
90  14 nM for WT and 150  18 nM for TKO mice (Fig. 4C). This
difference between the two genotypes is significant ( p  0.05).
Although DA release from TKO animals approached a plateau at
the same stimulus intensity (350 A) as in WT animals, the
amount of DA released during 60 Hz stimulation was higher at all
stimulus intensities tested (Fig. 4D) (main effect of genotype, F 
8.69, p  0.05). Saturation of the relationship between DA release
and stimulus intensity is thought to arise from saturating stimuli
maximally depolarizing the membrane potential and maximally
releasing DA from a restricted pool available for immediate re-
lease in response to such depolarization (Wiedemann et al.,
1990). Given that the ability of the stimuli to depolarize should be
similar between the two genotypes, the greater amount of DA
released at saturation suggests a larger pool of readily releasable
DA in TKO mice.
Calcium dependence of dopamine release
Given the essential role of calcium ions (Ca 2) in triggering neu-
rotransmitter release (Katz, 1969; Augustine et al., 1987; Neher,
1998), we next determined whether loss of synapsins affected the
calcium dependence of DA release. For this purpose, caudate–
putamen slices first were equilibrated in conventional aCSF con-
taining 2.4 mM Ca 2 and DA release produced by electrical
stimuli (single biphasic pulse, 2 ms each phase, 350 A) was
measured at a single location. This location was maintained
throughout the experiment while the Ca 2 concentration
([Ca 2]) was varied. Treatment with aCSF lacking Ca 2 was
then used to remove Ca 2 from the slice and the extracellular
[Ca 2] was subsequently increased incrementally from 0.5 to 5
mM. At each [Ca 2], slices were allowed to equilibrate for 35 min
and then were stimulated to evoke DA release. To compare the
absolute amount of DA released at each [Ca 2] between geno-
types, DA release at each [Ca 2] was divided by the DA release at
2.4 mM Ca 2 in WT slices and the resulting ratio was termed
“relative dopamine release.”
We found that the Ca 2 dependence of DA release differed
between slices from TKO and WT animals. At all Ca 2 concen-
trations examined, DA release was significantly higher in slices
from TKO mice than in WT slices ( p  0.001, n  5 for each
genotype) (Fig. 5A). To quantify the relationship between exter-
nal [Ca 2] and DA release, the data shown in Figure 5A were
replotted in logarithmic coordinates (Dodge and Rahamimoff,
1967; Augustine and Charlton, 1986). In this case, the sigmoidal
relationship between [Ca 2] and DA release is linearized, with
the slope of the line representing the amount of “cooperativity”
in Ca 2 triggering DA release and the [Ca 2] required for half-
maximal DA release reflecting the apparent Ca 2 affinity, KCa 2
(Dodge and Rahamimoff, 1967). To determine these two param-
eters, we fit the data with the Hill equation. Although the shapes
of these logarithmic plots were very similar for DA release from
both genotypes, we found that the TKO data were shifted toward
lower [Ca 2] (Fig. 5B). This leftward shift was due to a significant
difference in the apparent KCa 2 between the two genotypes:
2.80  0.27 mM for WT and 1.34  0.04 mM for TKO animals
( p  0.001). The Hill coefficient was similar for both genotypes
at 2.11  0.20 for WT animals and 2.73  0.22 for TKO animals
( p  0.05). These values for the Hill coefficient are similar to
those previously reported for depolarization-evoked DA release
from synaptosomes (Nachshen and Sanchez-Armass, 1987).
Thus, we conclude that the absence of synapsins raises the appar-
ent Ca 2 affinity of the DA release process without changing the
degree of cooperativity.
Figure 4. Electrically stimulated DA release in the striatum measured in vivo. A, Average
release profiles measured in WT and TKO mice (n8 for each) in response to 0.5 s stimulus train
(300 A, 20 Hz; ***p  0.001). B, [DA]max values exhibit similar frequency dependencies but
release is uniformly greater in TKO animals. C, [DA]p measured from the frequency-dependent
release shown in B (*p  0.05). D, Although similar responses to stimulus intensity (60 Hz
stimulations) are found in both genotypes, DA release is greater in TKO animals.
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Effects of cocaine on dopamine and serotonin release
The ability of cocaine to enhance DA release in vivo is reduced in
synapsin TKO mice (Venton et al., 2006). We therefore com-
pared the effects of cocaine on release of 5-HT and DA in these
mice. The effect of cocaine on 5-HT release in SNr brain slices was
evaluated by a 35 min application of cocaine (10 M), a concen-
tration that causes competitive inhibition of 5-HT transport
(John and Jones, 2007) and thereby increases the apparent value
of Km. Cocaine treatment caused dramatic changes in the shape
of the 5-HT concentration profile produced by electrical stimu-
lation (20 biphasic pulses, 2 ms each phase, 100 Hz, 350 A),
prolonging the time course of these signals in slices from both
WT and TKO mice (Fig. 6, left panels). This prolongation is due
to cocaine inhibiting 5-HT uptake. To estimate the apparent Km
for 5-HT uptake in the presence of cocaine (Jones et al., 1995), we
again used nonlinear regression to evaluate the decaying phase of
the 5-HT signal. The apparent Km values were 0.75  0.06 M for
WT and 0.83  0.09 M for TKO animals in the presence of
cocaine (n  7 for WT, n  6 for TKO), values that were larger
than the predrug value of 0.17 M (John et al., 2006). However,
the Km values measured in the presence of cocaine for each
genotype were not significantly different ( p  0.05) and were
similar to previous measurements made for 5-HT uptake in
the presence of 10 M cocaine (John and Jones, 2007). In
addition, cocaine treatment did not significantly ( p  0.05)
alter the amount of 5-HT released by electrical stimulation in
slices from either genotype: in the presence of 10 M cocaine,
the amplitude of 5-HT release was 110  6% of predrug values
in tissue from WT and 112  8% of predrug values in tissue
from TKO animals.
We next considered the influence of synapsins on the ability of
cocaine to increase DA release. The effect of cocaine on DA re-
lease evoked by electrical stimuli (single biphasic pulse, 2 ms each
phase, 350 A) was compared in caudate–putamen slices pre-
pared from the two mouse genotypes. These slices were treated
for 35 min with 2 M cocaine, a dose known to inhibit DA uptake
in mouse brain slices (Jones et al., 1995). Although uptake of DA
was much faster than that of 5-HT (compare traces in left and
right columns of Fig. 6), cocaine still caused a significant slowing
in the time course of the DA signal produced by electrical stimu-
lation (Fig. 6, right panels). This slowing indicates an inhibition
of DA uptake. The apparent Km values for DA uptake after appli-
cation of cocaine were 2.60  0.09 M for WT and 2.60  0.15
TKO M mice (n  7 for each genotype). While these values are
not significantly different from each other, they are substantially
larger than the value of 0.2 M measured in control conditions.
Cocaine treatment also caused an increase in the peak ampli-
tude of the DA signals. This finding is similar to observations in
rat (Jones et al., 1995) and mouse (Venton et al., 2006) brain
tissue. The stimulatory effect of cocaine on DA was much greater in
slices from WT mice than in slices from TKO mice (Fig. 6, right
panels). On average, cocaine increased electrically evoked DA release
by 89  4% in slices from WT mice, but only 49  3% in TKO slices
(Fig. 6). This difference between the cocaine responses of the two
genotypes is significant ( p  0.001; n  4 for each genotype).
We also examined the influence of external Ca 2 on the abil-
ity of cocaine to enhance DA release. Over the entire range of
[Ca 2] considered, cocaine caused a greater enhancement of DA
release from WT than from TKO slices ( p  0.001). Figure 7A
shows the relative DA release from both genotypes as a function
of the external [Ca 2] after all release values were normalized to
the value measured for WT samples at 2.4 mM Ca 2. The differ-
ence in Ca 2 sensitivity between WT and TKO animals shown in
Figure 5 was diminished by 2 M cocaine. Hill equation fits to
these data indicate that the apparent Ca 2 affinity, KCa 2, was
identical in the two genotypes, being 1.07  0.15 mM for WT and
1.09  0.13 mM for TKO. Likewise, the degree of cooperativity
was identical, with Hill coefficients of 2.19  0.43 for WT and
2.11  0.34 for TKO. Even in the presence of cocaine, the maxi-
mum values for relative DA release were still higher in TKO mice.
To further quantify the effects of cocaine on the Ca 2 depen-
dence of DA release, we calculated the ratio of DA release mea-
sured in the presence and absence of cocaine relative to the value
at 2.4 mM Ca 2 for each genotype (Fig. 7B). This ratio was sig-
nificantly greater than 1 when [Ca 2] was below 2.4 mM for WT
slices ( p  0.001, n  6), while TKO slices only showed signifi-
cant effects of cocaine at [Ca 2] of 1 mM or less ( p  0.001, n 
6). Therefore, we conclude that cocaine preferentially enhances
DA release from WT animals and that this enhancement depends
upon Ca 2 and synapsins.
Discussion
Our comparison of DA and 5-HT release from WT and synapsin-
deficient TKO mice revealed differences in the effect of synapsin
deletion on the release of these two monoamine neurotransmit-
ters. The amount of DA released by electrical stimuli was almost
twice as large in TKO mice as in WT controls. In contrast, 5-HT
release was unaltered in TKO mice. While cocaine blocked up-
take of both 5-HT and DA, raising the apparent value of Km in
both genotypes, it was able to enhance the release only of DA. The
enhancement of DA release by cocaine was greater in WT than in
Figure 5. Calcium dependence of DA release in striatal slices. A, Relative [DA]max for TKO and
WT animals at 0.5–5 mM extracellular [Ca 2]. TKO animals release significantly more DA at all
[Ca 2]. B, Log-plot used to determine stoichiometric relationship between DA release and
[Ca 2] using a fit to the Hill equation.
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TKO animals. The absence of synapsins
increased the apparent Ca 2 affinity of
the DA release process, an effect that was
mimicked by cocaine in WT tissue. Thus,
synapsins play very different roles in nerve
terminals using these two biogenic amine
neurotransmitters.
Synapsins regulate dopamine release
Greater DA release was observed in intact
TKO mice, in striatal brain slices prepared
from these mice, and in S3KO slices. This
establishes a role for synapsins in general,
and synapsin III in particular, in dopami-
nergic presynaptic terminals. Although
DA release was enhanced, uptake rates
and tissue DA content were similar in
TKO and WT mice. Thus, loss of syn-
apsins caused a change in the ability of
stimuli to release DA, rather than produc-
ing a change in the overall amount of DA
or altering the function of DAT. Despite
the increased amount of DA release in
TKO mice, the activity dependence of DA
release during repetitive activity was minimally affected. This
suggests that synapsins play only a minor role in replenishing the
readily releasable pool of DA.
Synapsins have a wide range of actions at different nerve ter-
minals. In the adult brain, loss of synapsins leads to a decrease in
the amount of GABA released by single stimuli, an effect likely
due to a reduction in the readily releasable pool of GABAergic
vesicles (Gitler et al., 2004; Baldelli et al., 2007). This action of
synapsins is thought to be mediated by synapsin I (Baldelli et al.,
2007). While release of glutamate in response to single stimuli is
unaffected by loss of synapsins, the kinetics of synaptic depres-
sion are accelerated (Gitler et al., 2004). This is thought to be due
to the ability of synapsin IIa to maintain glutamatergic synaptic
vesicles in a reserve pool (Gitler et al., 2008). Loss of synapsins
increases the release of catecholamines from adrenal chromaffin
cells by increasing the number of exocytotic events, an effect
rescued by expression of synapsin IIa (Villanueva et al., 2006).
These findings suggest that synapsins play different roles in nerve
terminals using different types of neurotransmitters.
The results of our analysis of monoamine neurotransmitter
release in synapsin TKO mice provide two additional lines of
support for the hypothesis that synapsins play different roles in
nerve terminals using different types of neurotransmitters. First,
release of 5-HT in response to brief trains of stimuli is unaffected
by the absence of synapsins. While it is possible that different
synapsins can have opposing effects on 5-HT release that are
neutralized by deleting all three synapsin genes, the most parsi-
monious explanation for our results is that synapsins do not reg-
ulate 5-HT release. This is similar to the case for acetylcholine
release at neuromuscular junctions, where transmission reportedly
is normal in TKO mice (Gaffield and Betz, 2007). The absence of an
effect of synapsins on 5-HT release may be due to the fact that 5-HT
is mainly stored in large dense-core vesicles (LDCVs) (Nirenberg
et al., 1995), while glutamate, GABA, and DA are primarily stored
in small synaptic vesicles (SSVs) (Nirenberg et al., 1997). In syn-
apses that contain both SSVs and LDCVs, synapsin I reportedly
associates only with SSVs (Navone et al., 1984). Thus, the lack of
effect on 5-HT release in TKO brain slices indicates that syn-
apsins do not regulate 5-HT release. Although synapsin I mRNA
Figure 6. Effects of cocaine on stimulated 5-HT and DA release and uptake in brain slices. Left traces, Representative responses
of 5-HT release in SNr from WT (upper) and TKO (lower) mice in the presence and absence of 10 M cocaine for 35 min. Right traces,
Representative responses of DA release in striatal tissue from WT (upper) and TKO (lower) mice measured before and 35 min after
the introduction of 2 M cocaine.
Figure 7. The effect of 2 M cocaine on the Ca 2 dependence of DA release in striatal slices
from WT and TKO mice. A, Relative [DA]max in TKO and WT animals as a function of extracellular
[Ca 2] in the presence of 2 M cocaine. Data are normalized relative to the amount of DA
release measured in WT slices at 2.4 mM Ca 2. TKO slices release more DA at all [Ca 2],
although little difference in the Ca 2 sensitivity of release is seen between the genotypes when
cocaine is present. B, Ratio of release in the presence of cocaine to that in its absence as a
function of external [Ca 2] for WT and TKO animals (n  6, each genotype); measured release
was normalized to release at 2.4 mM Ca 2 for each genotype. In slices from WT mice, cocaine
significantly increased electrically stimulated DA release at all [Ca 2] below 2.4 mM; however,
TKO animals are only facilitated at low levels of [Ca 2]. ***p  0.001 indicates significant
difference from 2.4 mM Ca 2.
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is expressed in the SNr (Allen Institute for Brain Discovery), it is
possible that this protein is not expressed in serotonergic nerve
terminals. Second, we found that release of DA in response to
single stimuli or brief trains of stimuli is enhanced in TKO ani-
mals. This is most likely due to loss of synapsin III, because DA
release was enhanced in slices from S3KO mice. These results are
consistent with the observation that the striatum is one of the few
locations where synapsin III is found in the adult mouse brain
(Pieribone et al., 2002). Even though the mRNAs for both syn-
apsins I and II are present in the striatum (Allen Institute for
Brain Discovery), neither isoform colocalizes with the vesicular
monoamine transporter 2 (VMAT2) so it is likely that synapsin
III is the synapsin isoform present in dopaminergic terminals
(Bogen et al., 2006). The fact that DA released by single, brief
stimuli was enhanced suggests that synapsin III serves as a nega-
tive regulator of the readily releasable pool of dopaminergic ves-
icles. This is reminiscent of the observation that S3KO mice have
an increased recycling pool of glutamatergic synaptic vesicles
(Feng et al., 2002), suggesting a general role for synapsin III as a
negative regulator of neurotransmitter release. The regulation of
DA release by synapsin III is even more intriguing in light of work
implicating synapsin III in schizophrenia, a disorder in which
altered DA signaling is thought to be important (Vawter et al.,
2002; Porton and Wetsel, 2007; Porton et al., 2010).
In summary, it seems clear that different synapsin isoforms
play distinct roles in nerve terminals using different neurotrans-
mitters. In some cases, synapsin I predominates, while in other
cases synapsins II or III are the primary regulators of neurotrans-
mitter release. Further, some synapsin isoform effects are limited
to vesicles in the reserve pool, while in other cases they more
directly influence exocytosis from the readily releasable pool of
vesicles [see Hilfiker et al. (1998) and Coleman and Bykhovskaia
(2009)]. Together, these findings extend the classical model of
synapsins maintaining the reserve pool of vesicles through
phosphorylation-sensitive tethers to the cytoskeleton (Greengard
et al., 1993).
Synapsin removal alters calcium and cocaine responses
Increasing extracellular [Ca 2] enhances neurotransmitter re-
lease by increasing Ca 2 entry into presynaptic terminals and
subsequent accumulation of Ca 2 within the terminal cytoplasm
(Augustine and Charlton, 1986; Nachshen and Sanchez-Armass,
1987). We found that terminals from TKO mice were more sen-
sitive to extracellular [Ca 2] than terminals from WT mice,. The
higher saturation value of DA release reached in TKO animals
(Fig. 5) provides another indication that synapsins serve as a
negative regulator of the readily releasable pool of dopaminergic
vesicles.
Cocaine inhibits the DA transporter, thereby increasing extra-
cellular DA concentrations (Jones et al., 1996). Cocaine also fa-
cilitates DA release from presynaptic terminals (Lee et al., 2001)
by a synapsin-dependent effect (Venton et al., 2006). The present
work confirms this cocaine-induced enhancement of DA release
and demonstrates that it is significantly less in tissue from synap-
sin TKO animals (Fig. 6). In WT tissue, cocaine enhances both
DA release and Ca 2 sensitivity (compare Fig. 5A and Fig. 7A) to
values similar to those obtained in TKO tissue without cocaine. It
is unclear how cocaine affects the Ca 2 sensitivity of release;
cocaine can increase intracellular Ca 2 levels in brain cells (Du et
al., 2006), which would be expected to increase the sensitivity of
DA release to extracellular Ca 2 levels. This effect is not pro-
duced by methylphenidate, indicating that cocaine could in-
crease DA release via a DAT-independent pathway (Du et al.,
2006). Cocaine also has been proposed to alter calcium influx
through calcium channels (Han et al., 2002), which would also
produce an increase in the sensitivity of DA release to extracellu-
lar Ca 2. The fact that cocaine can increase DA release in TKO
slices at low [Ca 2] (Fig. 7B) indicates the presence of a second,
minor pathway for enhancing DA release that is independent of
synapsins. This effect may be minor because DA release is already
close to saturation in TKO tissue.
Cocaine is also a potent inhibitor of the 5-HT transporter (Uhl
et al., 2002; Uhl and Lin, 2003). Our measurements in the SNr
confirm this action of cocaine by showing that the rate of uptake
of 5-HT was lowered in the presence of the drug. However, unlike
its effects on DA release, cocaine does not enhance 5-HT release
(Fig. 6). Furthermore, there is no difference in the cocaine sensi-
tivity of 5-HT uptake between WT mice and synapsin TKO mice.
These distinctions between the actions of cocaine on dopaminer-
gic and serotonergic neurons may reflect the different roles that
synapsins play in terminals using DA and 5-HT.
In conclusion, the loss of synapsins alters DA release, but not
5-HT release, from presynaptic terminals. The similar enhance-
ment of DA release that occurs in synapsin III KO mice empha-
sizes the predominant role of this synapsin isoform in regulating
DA release. The ability of calcium to trigger exocytosis of DA was
also enhanced by the absence of synapsins. Cocaine enhanced the
Ca 2 sensitivity of DA release in WT slices to a level found in
TKO tissue, further demonstrating the importance of synapsins
for Ca 2 regulation of DA release. Together, our results indicate
that synapsins have dramatically different functions at presynap-
tic terminals that employ different neurotransmitters. These
findings should stimulate future efforts to understand the molec-
ular mechanisms underlying the diverse actions of synapsins.
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